<DOC>
	<DOCNO>NCT00242099</DOCNO>
	<brief_summary>Human herpesvirus-6 ( HHV-6 ) -7 ( HHV-7 ) infection common transplantation . Such infection may predispose transplant patient infection , contribute recurrence hepatitis C virus , affect rejection function transplant liver . Given significant clinical impact virus , routine laboratory monitoring may beneficial identify patient persistent high level infection . In patient , immunosuppressive medication could adjust , antiviral medication administer . There currently randomize trial address important question . This prospective , randomized trial analyze whether routine laboratory monitor HHV-6 -7 clinically useful , whether would improve overall outcome transplant recipient .</brief_summary>
	<brief_title>Clinical Utility Monitoring Human Herpesvirus-6 ( HHV-6 ) Human Herpesvirus-7 ( HHV-7 ) After Liver Transplant</brief_title>
	<detailed_description />
	<criteria>Male female patient fulfill follow criterion eligible inclusion : Recipients liver transplant Able give write informed consent Are willing able comply protocol Age &gt; = 18 year The following patient eligible inclusion study : Patients unwilling unable give inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2005</verification_date>
	<keyword>liver transplant</keyword>
	<keyword>HHV-6</keyword>
	<keyword>HHV-7</keyword>
	<keyword>Human Herpesvirus-6</keyword>
	<keyword>Human Herpesvirus-7</keyword>
</DOC>